Literature DB >> 7542281

Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors.

D Salvemini1, P T Manning, B S Zweifel, K Seibert, J Connor, M G Currie, P Needleman, J L Masferrer.   

Abstract

We have recently put forward the hypothesis that the dual inhibition of proinflammatory nitric oxide (NO) and prostaglandins (PG) may contribute to the antiinflammatory properties of nitric oxide synthase (NOS) inhibitors. This hypothesis was tested in the present study. A rapid inflammatory response characterized by edema, high levels of nitrites (NO2-, a breakdown product of NO), PG, and cellular infiltration into a fluid exudate was induced by the administration of carrageenan into the subcutaneous rat air pouch. The time course of the induction of inducible nitric oxide synthase (iNOS) protein in the pouch tissue was found to coincide with the production of NO2-. Dexamethasone inhibited both iNOS protein expression and NO2- synthesis in the fluid exudate (IC50 = 0.16 mg/kg). Oral administration of N-iminoethyl-L-lysine (L-NIL) or NG-nitro-L-arginine methyl ester (NO2Arg) not only blocked nitrite accumulation in the pouch fluid in a dose-dependent fashion but also attenuated the elevated release of PG. Finally, carrageenan administration produced a time-dependent increase in cellular infiltration into the pouch exudate that was inhibited by dexamethasone and NOS inhibitors. At early times, i.e., 6 h, the cellular infiltrate is composed primarily of neutrophils (98%). Pretreatment with colchicine reduced both neutrophil infiltration and leukotriene B4 accumulation in the air pouch by 98% but did not affect either NO2- or PG levels. In conclusion, the major findings of this paper are that (a) selective inhibitors of iNOS are clearly antiinflammatory agents by inhibiting not only NO but also PG and cellular infiltration and (b) that neutrophils are not responsible for high levels of NO and PG produced.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542281      PMCID: PMC185201          DOI: 10.1172/JCI118035

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

Review 1.  Rheumatoid arthritis and osteoarthritis: current and future therapies.

Authors:  B L Flynn
Journal:  Am Pharm       Date:  1994-11

2.  Role of inducible cyclooxygenase (COX-2) in inflammation.

Authors:  K Seibert; J L Masferrer
Journal:  Receptor       Date:  1994

3.  Regulation of prostaglandin synthesis by glucocorticoids.

Authors:  J L Masferrer; K Seibert
Journal:  Receptor       Date:  1994

4.  Regulation of prostaglandin production by nitric oxide; an in vivo analysis.

Authors:  D Salvemini; S L Settle; J L Masferrer; K Seibert; M G Currie; P Needleman
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

5.  IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide.

Authors:  J A Corbett; G Kwon; J Turk; M L McDaniel
Journal:  Biochemistry       Date:  1993-12-21       Impact factor: 3.162

6.  In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages.

Authors:  J L Masferrer; S T Reddy; B S Zweifel; K Seibert; P Needleman; R S Gilbert; H R Herschman
Journal:  J Pharmacol Exp Ther       Date:  1994-09       Impact factor: 4.030

7.  Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation.

Authors:  D Salvemini; K Seibert; J L Masferrer; T P Misko; M G Currie; P Needleman
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

Authors:  J R Vane; J A Mitchell; I Appleton; A Tomlinson; D Bishop-Bailey; J Croxtall; D A Willoughby
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

9.  Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase.

Authors:  J R Connor; P T Manning; S L Settle; W M Moore; G M Jerome; R K Webber; F S Tjoeng; M G Currie
Journal:  Eur J Pharmacol       Date:  1995-01-24       Impact factor: 4.432

10.  L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.

Authors:  W M Moore; R K Webber; G M Jerome; F S Tjoeng; T P Misko; M G Currie
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

View more
  42 in total

1.  Calpain inhibitor I reduces the development of acute and chronic inflammation.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; D Siriwardena; I Serraino; L Dugo; D Britti; G Mazzullo; A P Caputi; C Thiemermann
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; D Siriwardena; G Calabrò; D Britti; G Mazzullo; A De Sarro; A P Caputi; C Thiemermann
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

3.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Neutrophils-derived peroxynitrite contributes to acute hyperalgesia and cell influx in zymosan arthritis.

Authors:  Mirna M Bezerra; Susan D Brain; Virgínia C C Girão; Stan Greenacre; Julie Keeble; Francisco A C Rocha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-15       Impact factor: 3.000

Review 5.  Nitric oxide signalling in the brain and its control of bodily functions.

Authors:  Konstantina Chachlaki; Vincent Prevot
Journal:  Br J Pharmacol       Date:  2019-09-08       Impact factor: 8.739

6.  Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice.

Authors:  S Cuzzocrea; C Crisafulli; E Mazzon; E Esposito; C Muià; M Abdelrahman; R Di Paola; C Thiemermann
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

7.  Pathophysiological basis of acute inflammatory hyperaemia in the rat knee: roles of cyclo-oxygenase-1 and -2.

Authors:  Colin G Egan; John C Lockhart; William R Ferrell; Suzanne M Day; John S McLean
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

Review 8.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

9.  Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.

Authors:  D Salvemini; M G Currie; V Mollace
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Protein nitration in cutaneous inflammation in the rat: essential role of inducible nitric oxide synthase and polymorphonuclear leukocytes.

Authors:  S A B Greenacre; F A C Rocha; A Rawlingson; S Meinerikandathevan; R N Poston; E Ruiz; B Halliwell; S D Brain
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.